Preliminary experience with the use of bendamustine: a peculiar skin rash as the commonest side effect
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology,General Medicine
Reference12 articles.
1. Bendamustine in B-cell Malignancies: The new 46-year-old kid on the block;Gandhi;Clin Cancer Res,2009
2. Bendamustine in patients with rituximabrefractory indolent and transformed non-Hodgkin’s lymphoma: results from a phase II multicenter, singleagent study;Friedberg;J Clin Oncol,2008
3. Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin’s lymphoma;Robinson;J Clin Oncol,2008
4. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia;Knauf;J Clin Oncol,2009
5. Bendamustine plus rituximab versus CHOP Plus Rituximab in the First-Line-Treatment of Patients with Follicular, Indolent and Mantle Cell Lymphomas: Results of a Randomized Phase III study of the study group indolent lymphomas (StiL);Rummel;ASH Annual Meeting Abstracts,2008
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients;Indian Journal of Hematology and Blood Transfusion;2022-05-27
2. Risk Factors for Skin Toxicities Associated with Bendamustine-Based Chemotherapy in Patients with Non-Hodgkin Lymphoma;Biological and Pharmaceutical Bulletin;2020-10-01
3. Bullae And Blisters: A Rare Case of Bendamustine Skin Toxicity;Indian Journal of Hematology and Blood Transfusion;2016-02-04
4. Increased number of peripheral CD8+ T cells but not eosinophils is associated with late-onset skin reactions caused by bendamustine;International Journal of Hematology;2015-04-02
5. Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab;Case Reports in Oncology;2014-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3